The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34+ Cell Administration in Patients With Refractory Angina

RENEW Investigators

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint Dive into the research topics of 'The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34<sup>+</sup> Cell Administration in Patients With Refractory Angina'. Together they form a unique fingerprint.

Medicine & Life Sciences